Friday, December 30, 2022

Your Post-Notable Earnings Report (Dec 30)

Open Now...Your Morning Report Inside…Post Earnings for Major Stocks
Your Notable Earnings Report

Unsubscribe


New Year Sale. Buy Weekly Spread Trader...Get Institutional Spread Trader for FREE
Dear Reader,
I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of major stocks which reported Earnings a few days ago with Earnings Surprise (to help you find Post-Earnings trading and/or investing opportunities).

Your Buy Buy Alert (Fast Money Trader. Lifetime Access)
Sign Up and Get Your 1st Stock Trade Alert Today (Friday, Dec 30) at 12pm EST Sign Up and Get Your 1st Stock Trade Alert Today (Friday, Dec 30) at 12pm EST

Symbol CompanyEarning DateEPS Surprise %
RAD12/21 before 56.25%
CCL12/21 before 4.49%
MU12/21 After -15.38%
FCEL12/20 before -57.14%
BB12/20 before 33.33%
FDX12/20 before 14.80%
NKE12/20 After 30.77%
ACN12/16 before 5.84%
ADBE12/15 before 0.00%
LEN12/14 before 2.03%
COUP12/12 After -11.29%
ORCL12/12 After -2.06%
LI12/09 before 4.00%
EXPR12/08 before -72.41%
CIEN12/08 before 800.00%
LOAD MORE
sun Before Market Opensun After Market Close

[Ad] The One Ticker Retirement Plan
How to make all the money you need — in any market — using a single stock. See below for the name of the ticker… Click to Watch it here…

[Ad] 5 NASDAQ Stocks to Own for New Year 2023
Even in the worst of times, markets have rallied back. Just as they always have. So, if you're thinking of quitting the market, don't.(By clicking this link you agree to receive emails from Investing District. Unsubscribing is easy) Click Here to make your MOVE!

How to use EPS Surprice in your Post-Earnings trading strategies:
Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's earnings announcement) or the Price Reversal strategy (to target the reversal of next-day big price movement). Please click on Ride-the-Wave Strategy to learn more about it.
Stock Trading - If you're a stock trader/investor or portfolio manager, you may want to consider adjusting your positiosn based on a EPS surprise reported by the company.
At Daily Options Signals, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader.
To your trading success,
Hiral Ghelani
Founder & CEO
Daily Options Signals, Inc
110 Wall Street, Suite #2046, New York, NY 10005
W: 877.6.STOCKS (Mon to Sat | 9am to 5pm EST | Feel Free to Call Us)
PS: Daily Options Signals is morning newsletter, powered by StockEarnings.com proprietary technology.

Daily Options Signals, Inc (SE) is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities.

This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "Ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised.

All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers.

Unsubscribe

No comments:

Post a Comment

Skirmish over paper drug info draws on

Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy...